ClinicalTrials.Veeva

Menu

Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)

University of Miami logo

University of Miami

Status

Withdrawn

Conditions

PTSD
Virus, Human Immunodeficiency
Depression

Treatments

Behavioral: WAVE-TW

Study type

Interventional

Funder types

Other

Identifiers

NCT04305977
20190722

Details and patient eligibility

About

WAVE - TW (Writing to Alleviate Violence Exposure for Transgender women living with HIV) is an intervention development study which aims to assess the feasibility and acceptability of a proposed trauma writing and adherence intervention that addresses Post-Traumatic Stress Disorder (PTSD) and depressive symptoms, antiretroviral therapy (ART) adherence and viral suppression among transgender women.

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Living with HIV
  • Age 18 or older
  • Detectable viral load within the past year
  • Transgender female
  • English speaking
  • Capable of completing and fully understanding the informed consent process and the study procedures
  • History of trauma/abuse

Exclusion criteria

  • Unable to completely and fully understand the consent process and the study procedures.
  • Significant interfering mental health symptoms (e.g., untreated active psychosis, active suicidality with a plan).
  • Engaged in an intervention to address trauma symptoms and adherence within the past year

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

WAVE-TW Arm
Other group
Description:
All participants will receive the WAVE-TW intervention.
Treatment:
Behavioral: WAVE-TW

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems